We are live on ! Find out more
SRC

Shufro Rose & Co Portfolio holdings

AUM $1.47B
1-Year Est. Return 19.38%
This Fund
S&P 500
This Quarter Est. Return
+7.08%
1 Year Est. Return
+19.38%
3 Year Est. Return
+47.49%
5 Year Est. Return
+55.37%
10 Year Est. Return
+200.77%
AUM
$1.21B
AUM Growth
+$158M
Cap. Flow
+$11.5M
Cap. Flow %
0.95%
Top 10 Hldgs %
38.56%
Holding
345
New
37
Increased
103
Reduced
110
Closed
29

Sector Composition

Rank Sector Weight
1 Technology 18.58%
2 Healthcare 9.87%
3 Consumer Discretionary 9.58%
4 Financials 8.26%
5 Industrials 4.17%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BWA icon
26
BorgWarner
BWA
$12.8B
$12.7M 1.05%
364,929
+13,675
+4% +$447K
BIL icon
27
State Street SPDR Bloomberg 1-3 Month T-Bill ETF
BIL
$47.1B
$12.3M 1.02%
134,494
+6,999
+5% +$641K
AMGN icon
28
Amgen
AMGN
$209B
$12M 0.99%
42,136
-123
-0.3% -$36K
IVV icon
29
iShares Core S&P 500 ETF
IVV
$858B
$12M 0.99%
+22,756
New +$11.4M
IBM icon
30
IBM
IBM
$213B
$11.8M 0.97%
61,837
+52,467
+560% +$9.57M
LEN icon
31
Lennar Class A
LEN
$20.4B
$11.5M 0.95%
68,928
-1,718
-2% -$258K
BSCP
32
DELISTED
Invesco BulletShares 2025 Corporate Bond ETF
BSCP
$10.5M 0.87%
514,328
+18,154
+4% +$371K
QUAL icon
33
iShares MSCI USA Quality Factor ETF
QUAL
$45.7B
$10.3M 0.85%
62,379
+1,127
+2% +$176K
IGSB icon
34
iShares 1-5 Year Investment Grade Corporate Bond ETF
IGSB
$23B
$9.84M 0.81%
191,844
-72,606
-27% -$3.72M
COHR icon
35
Coherent
COHR
$43.4B
$9.33M 0.77%
153,929
+1,660
+1% +$91K
CRM icon
36
Salesforce
CRM
$154B
$9.25M 0.76%
30,722
+751
+3% +$217K
WD icon
37
Walker & Dunlop
WD
$1.73B
$8.47M 0.7%
83,804
-1,826
-2% -$175K
VCSH icon
38
Vanguard Short-Term Corporate Bond ETF
VCSH
$44.7B
$7.83M 0.65%
101,326
+704
+0.7% +$54.3K
AZO icon
39
AutoZone
AZO
$51.3B
$7.64M 0.63%
2,423
-69
-3% -$197K
XOM icon
40
ExxonMobil
XOM
$650B
$7.24M 0.6%
62,274
+1,155
+2% +$121K
VBR icon
41
Vanguard Morningstar Small-Cap Value ETF
VBR
$37.2B
$7.22M 0.6%
37,644
+4,713
+14% +$850K
NEAR icon
42
iShares Short Maturity Bond ETF
NEAR
$4.82B
$6.92M 0.57%
137,098
-26,667
-16% -$1.35M
ITW icon
43
Illinois Tool Works
ITW
$84.1B
$6.29M 0.52%
23,440
-615
-3% -$160K
VO icon
44
Vanguard Morningstar Mid-Cap ETF
VO
$106B
$6.26M 0.52%
100,212
-124,532
-55% -$7.36M
BSV icon
45
Vanguard Short-Term Bond ETF
BSV
$44.7B
$5.92M 0.49%
77,178
-60,737
-44% -$4.66M
CVX icon
46
Chevron
CVX
$382B
$5.83M 0.48%
36,973
-422
-1% -$63.7K
UL icon
47
Unilever
UL
$142B
$5.62M 0.46%
99,572
-1,304
-1% -$72.2K
BSCS icon
48
Invesco BulletShares 2028 Corporate Bond ETF
BSCS
$3.56B
$5.41M 0.45%
+269,793
New +$5.42M
DIS icon
49
Walt Disney
DIS
$171B
$5.34M 0.44%
43,607
-688
-2% -$71.9K
MET icon
50
MetLife
MET
$62.4B
$5.14M 0.42%
69,410
-1,446
-2% -$101K

Similar funds

Shufro Rose & Co's Q1 2024 Portfolio in Review

As of Q1 2024, Shufro Rose & Co held 345 positions worth $1.21B, up 15% from $1.05B the previous quarter. Its ten largest holdings account for 39% of the portfolio.

Shufro Rose & Co's Q1 2024 filing shows 37 new, 103 increased, 110 reduced and 29 closed positions. Its largest new stake was Moderna: 146,584 shares worth $15.6M. The largest sale was iShares iBonds Dec 2026 Term Corporate ETF, an estimated $41.5M.

By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 19% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Shufro Rose & Co's largest Q1 2024 buy was Moderna: 146,584 shares worth $15.6M.
  • Shufro Rose & Co added most to iShares iBonds Dec 2027 Term Corporate ETF in Q1 2024, an estimated $121M increase.
  • Shufro Rose & Co's biggest Q1 2024 reduction was iShares iBonds Dec 2026 Term Corporate ETF, cutting an estimated $41.5M.
  • Shufro Rose & Co fully exited Horizon Kinetics Inflation Beneficiaries ETF in Q1 2024, selling an estimated $34.8M.
  • Shufro Rose & Co's ten largest holdings make up 39% of its $1.21B portfolio in Q1 2024.
  • Shufro Rose & Co opened 37 new positions and closed 29 in Q1 2024.
  • Shufro Rose & Co's portfolio value rose 15% quarter-over-quarter to $1.21B.

Based on Shufro Rose & Co's 13F filing for Q1 2024, filed 8 May 2024.